Genomics Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global genomics market looks promising with opportunities in functional genomics, epigenetics, pathway analysis, and biomarker discovery applications. The global genomics market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing use of genomics in research and development of new drugs, and increasing number of genomic projects.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genomics market report, please download the report brochure.
In this market, polymerase chain reaction is the largest technology of genomics, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the genomics market are given below:
The study includes trends and forecast for the global genomics market by deliverable, technology, application, end user, and region as follows:
By Deliverable [Value ($ Million) shipment analysis for 2014 – 2025]:
ProductsInstruments and SoftwaresConsumables and ReagentsServicesCore Genomics ServicesNGS-based ServicesBiomarker Translation ServicesComputational ServicesOthers
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Polymerase Chain Reaction (PCR)SequencingMicroarrayNucleic Acid Extraction and PurificationOther Technologies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Functional GenomicsEpigeneticsPathway AnalysisBiomarker DiscoveryOthers
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Clinical and Research LaboratoriesAcademic and Government InstitutesHospitals and ClinicsPharmaceutical and Biotechnology CompaniesOther End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the genomics companies profiled in this report include F. Hoffmann-La Roche, Agilent Technologies, Thermo Fisher Scientific, Bio-Rad Laboratories, 23andMe, Illumina, Myriad Genetics, Foundation Medicine, Danaher; and Pacific Biosciences.
Lucintel forecasts that polymerase chain reaction (PCR) will remain the largest segment over the forecast period as it is less costly for DNA amplification process as compare to other technologies.
Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to increasing genetic research studies and increasing applications of genomics for drugs in diseases related to immune system, central nervous system, and cardiovascular system.
North America will remain the largest region over the forecast period due to due to increasing research activities by government organisations and increasing awareness of patients.
Features of the Global Genomics Market
Market Size Estimates: Global genomics market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global genomics market size by various segments, such as deliverable, technology, application, and end user in terms of value.Regional Analysis: Global genomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different deliverable, technology, application, end user, and region for the global genomics market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global genomics market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global genomics market by deliverable (products (instruments and softwares and consumables and reagents) and services (core genomics services, NGS-based services, biomarker translation services, computational services, and others)), technology (polymerase chain reaction (PCR), sequencing, microarray, nucleic acid extraction and purification, and other technologies), application (functional genomics, epigenetics, pathway analysis, biomarker discovery, and others), end user (clinical and research laboratories, academic and government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users) and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genomics market?
Q.5 What are the business risks and threats to the global genomics market?
Q.6 What are the emerging trends in this genomics market and the reasons behind them?
Q.7 What are some changing demands of customers in this genomics market?
Q.8 What are the new developments in this genomics market? Which companies are leading these developments?
Q.9 Who are the major players in this genomics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this genomics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global genomics market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Deliverables (Products and Services), Technology (Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies), Application (Functional Genomics, Epigenetics, Pathway Analysis, Biomarker Discovery, and Others), and End User (Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global genomics market looks promising with opportunities in functional genomics, epigenetics, pathway analysis, and biomarker discovery applications. The global genomics market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing use of genomics in research and development of new drugs, and increasing number of genomic projects.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genomics market report, please download the report brochure.
In this market, polymerase chain reaction is the largest technology of genomics, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the genomics market are given below:
The study includes trends and forecast for the global genomics market by deliverable, technology, application, end user, and region as follows:
By Deliverable [Value ($ Million) shipment analysis for 2014 – 2025]:
ProductsInstruments and SoftwaresConsumables and ReagentsServicesCore Genomics ServicesNGS-based ServicesBiomarker Translation ServicesComputational ServicesOthers
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Polymerase Chain Reaction (PCR)SequencingMicroarrayNucleic Acid Extraction and PurificationOther Technologies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Functional GenomicsEpigeneticsPathway AnalysisBiomarker DiscoveryOthers
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Clinical and Research LaboratoriesAcademic and Government InstitutesHospitals and ClinicsPharmaceutical and Biotechnology CompaniesOther End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the genomics companies profiled in this report include F. Hoffmann-La Roche, Agilent Technologies, Thermo Fisher Scientific, Bio-Rad Laboratories, 23andMe, Illumina, Myriad Genetics, Foundation Medicine, Danaher; and Pacific Biosciences.
Lucintel forecasts that polymerase chain reaction (PCR) will remain the largest segment over the forecast period as it is less costly for DNA amplification process as compare to other technologies.
Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to increasing genetic research studies and increasing applications of genomics for drugs in diseases related to immune system, central nervous system, and cardiovascular system.
North America will remain the largest region over the forecast period due to due to increasing research activities by government organisations and increasing awareness of patients.
Features of the Global Genomics Market
Market Size Estimates: Global genomics market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global genomics market size by various segments, such as deliverable, technology, application, and end user in terms of value.Regional Analysis: Global genomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different deliverable, technology, application, end user, and region for the global genomics market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global genomics market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global genomics market by deliverable (products (instruments and softwares and consumables and reagents) and services (core genomics services, NGS-based services, biomarker translation services, computational services, and others)), technology (polymerase chain reaction (PCR), sequencing, microarray, nucleic acid extraction and purification, and other technologies), application (functional genomics, epigenetics, pathway analysis, biomarker discovery, and others), end user (clinical and research laboratories, academic and government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users) and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genomics market?
Q.5 What are the business risks and threats to the global genomics market?
Q.6 What are the emerging trends in this genomics market and the reasons behind them?
Q.7 What are some changing demands of customers in this genomics market?
Q.8 What are the new developments in this genomics market? Which companies are leading these developments?
Q.9 Who are the major players in this genomics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this genomics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global genomics market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Deliverables (Products and Services), Technology (Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies), Application (Functional Genomics, Epigenetics, Pathway Analysis, Biomarker Discovery, and Others), and End User (Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Genomics Market Trends and Forecast
3.3: Global Genomics Market by Deliverable
3.3.1: Products
3.3.1.1: Instruments and Softwares
3.3.1.2: Consumables and Reagents
3.3.2: Services
3.3.2.1: Core Genomics Services
3.3.2.2: NGS-based Services
3.3.2.3: Biomarker Translation Services
3.3.2.4: Computational Services
3.3.2.5: Others
3.4: Global Genomics Market by Technology
3.4.1: Polymerase Chain Reaction (PCR)
3.4.2: Sequencing
3.4.3: Microarray
3.4.4: Nucleic Acid Extraction and Purification
3.4.5: Other Technologies
3.5: Global Genomics Market by Application
3.5.1: Functional Genomics
3.5.2: Epigenetics
3.5.3: Pathway Analysis
3.5.4: Biomarker Discovery
3.5.5: Others
3.6: Global Genomics Market by End User
3.6.1: Clinical and Research Laboratories
3.6.2: Academic and Government Institutes
3.6.3: Hospitals and Clinics
3.6.4: Pharmaceutical and Biotechnology Companies
3.6.5: Other End Users
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Genomics Market by Region
4.2: North American Genomics Market
4.2.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others
4.2.2: Market by Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.2.3: Market by Application: Functional Genomics, Epigenetics, Pathway Analysis, Biomarker Discovery, and Others
4.2.4: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.2.5: The United States Genomics Market
4.2.6: The Canadian Genomics Market
4.2.7: The Mexican Genomics Market
4.3: European Genomics Market
4.3.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others
4.3.2: Market by Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.3.3: Market by Application: Functional Genomics, Epigenetics, Pathway Analysis, Biomarker Discovery, and Others
4.3.4: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.3.5: The Genomics Market of United Kingdom
4.3.6: The German Genomics Market
4.3.7: The French Genomics Market
4.4: APAC Genomics Market
4.4.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others
4.4.2: Market by Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.4.3: Market by Application: Functional Genomics, Epigenetics, Pathway Analysis, Biomarker Discovery, and Others
4.4.4: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.4.5: The Chinese Genomics Market
4.4.6: The Indian Genomics Market
4.4.7: The Japanese Genomics Market
4.5: ROW Genomics Market
4.5.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others
4.5.2: Market by Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.5.3: Market by Application: Functional Genomics, Epigenetics, Pathway Analysis, Biomarker Discovery, and Others
4.5.4: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.5.5: Brazilian Genomics Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Genomics Market by Deliverable
7.1.2: Growth Opportunities for the Global Genomics Market by Technology
7.1.3: Growth Opportunities for the Global Genomics Market by Application
7.1.4: Growth Opportunities for the Global Genomics Market by End User
7.1.5: Growth Opportunities for the Global Genomics Market by Region
7.2: Emerging Trends in the Global Genomics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Genomics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Genomics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: F. Hoffmann-La Roche Ltd.
8.2: Agilent Technologies
8.3: Therm Fisher Scientific, Inc.
8.4: Bio-Rad Laboratories, Inc.
8.5: 23andMe, Inc.
8.6: Illumina, Inc.
8.7: Myriad Genetics, Inc.
8.8: Foundation Medicine, Inc.
8.9: Danaher
8.10: Pacific Biosciences
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Genomics Market Trends and Forecast
3.3: Global Genomics Market by Deliverable
3.3.1: Products
3.3.1.1: Instruments and Softwares
3.3.1.2: Consumables and Reagents
3.3.2: Services
3.3.2.1: Core Genomics Services
3.3.2.2: NGS-based Services
3.3.2.3: Biomarker Translation Services
3.3.2.4: Computational Services
3.3.2.5: Others
3.4: Global Genomics Market by Technology
3.4.1: Polymerase Chain Reaction (PCR)
3.4.2: Sequencing
3.4.3: Microarray
3.4.4: Nucleic Acid Extraction and Purification
3.4.5: Other Technologies
3.5: Global Genomics Market by Application
3.5.1: Functional Genomics
3.5.2: Epigenetics
3.5.3: Pathway Analysis
3.5.4: Biomarker Discovery
3.5.5: Others
3.6: Global Genomics Market by End User
3.6.1: Clinical and Research Laboratories
3.6.2: Academic and Government Institutes
3.6.3: Hospitals and Clinics
3.6.4: Pharmaceutical and Biotechnology Companies
3.6.5: Other End Users
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Genomics Market by Region
4.2: North American Genomics Market
4.2.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others
4.2.2: Market by Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.2.3: Market by Application: Functional Genomics, Epigenetics, Pathway Analysis, Biomarker Discovery, and Others
4.2.4: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.2.5: The United States Genomics Market
4.2.6: The Canadian Genomics Market
4.2.7: The Mexican Genomics Market
4.3: European Genomics Market
4.3.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others
4.3.2: Market by Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.3.3: Market by Application: Functional Genomics, Epigenetics, Pathway Analysis, Biomarker Discovery, and Others
4.3.4: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.3.5: The Genomics Market of United Kingdom
4.3.6: The German Genomics Market
4.3.7: The French Genomics Market
4.4: APAC Genomics Market
4.4.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others
4.4.2: Market by Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.4.3: Market by Application: Functional Genomics, Epigenetics, Pathway Analysis, Biomarker Discovery, and Others
4.4.4: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.4.5: The Chinese Genomics Market
4.4.6: The Indian Genomics Market
4.4.7: The Japanese Genomics Market
4.5: ROW Genomics Market
4.5.1: Market by Deliverable: Products (Instruments and Softwares and Consumables and reagents) and Services (Core Genomics Services, NGS-based Services, Biomarker Translation Services, Computational Services, and Others
4.5.2: Market by Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Technologies
4.5.3: Market by Application: Functional Genomics, Epigenetics, Pathway Analysis, Biomarker Discovery, and Others
4.5.4: Market by End User: Clinical and Research Laboratories, Academic and Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users
4.5.5: Brazilian Genomics Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Genomics Market by Deliverable
7.1.2: Growth Opportunities for the Global Genomics Market by Technology
7.1.3: Growth Opportunities for the Global Genomics Market by Application
7.1.4: Growth Opportunities for the Global Genomics Market by End User
7.1.5: Growth Opportunities for the Global Genomics Market by Region
7.2: Emerging Trends in the Global Genomics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Genomics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Genomics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: F. Hoffmann-La Roche Ltd.
8.2: Agilent Technologies
8.3: Therm Fisher Scientific, Inc.
8.4: Bio-Rad Laboratories, Inc.
8.5: 23andMe, Inc.
8.6: Illumina, Inc.
8.7: Myriad Genetics, Inc.
8.8: Foundation Medicine, Inc.
8.9: Danaher
8.10: Pacific Biosciences
